Opentrons, Pandemic Response Lab
Samuel Davalos began their career in 2015 as a Molecular Technologist at MedLabs Diagnostics, where they gained expertise in a variety of molecular methods and instrumentation. Samuel then moved up to the position of Director of Technical Innovation in 2017, where they oversaw assay transition and setup, analyzed send out costs, and implemented cost reduction strategies.
In 2019, Samuel joined Siemens Healthineers as an Automation Informatics Specialist, responsible for installing and configuring informatics products across the Northeast United States. Samuel then joined Eurofins NTD Genetics in 2020 as the Associate Vice President of Operations. In this role, they served as the Acting Business Unit Manager and focused on cross-functional processes and policies.
Samuel's most recent position is with Opentrons' Pandemic Response Lab as the SVP of Laboratory Operations, which they started in 2022.
Samuel Davalos completed their Bachelor's degree in Biochemistry and Molecular Biology from Colgate University between 2010 and 2014. Before attending Colgate University, they attended Regis High School from 2006 to 2010. No specific degree or field of study was mentioned during their time at Regis High School.
This person is not in any teams
Opentrons, Pandemic Response Lab
Pandemic Response Lab (PRL) provides high-volume, low-cost COVID-19 testing, variant detection, sequencing, pooling, population testing, and PCR-based respiratory panels to communities across the U.S. PRL is led by a team of experts in genetics, clinical diagnostics, and robotics. Our state-of-the-art labs use knowledge and technology licensed from NYU Langone based on research led by world-class geneticist Dr. Jef Boeke. PRL is a subsidiary of Opentrons Labworks Inc., a leading diagnostic life sciences company based in NY. Since its founding in early 2020, PRL has opened 3 locations in Long Island City, NY; Rockville, MD; and Irvine, CA, with plans for expansion in the near future. PRL is leveraging innovation in science and robotics to address a provider, payer and patient care system challenged for years in lowering costs and providing optimal patient care.